Sarah Carmody

No open positions remaining

Health Technology

Profile

Sarah Carmody worked as an Executive Director-Investor & Communications at Mersana Therapeutics, Inc. from 2018 to 2022.
She also served as an Investor Relations Contact at Momenta Pharmaceuticals, Inc. and as a Manager-Corporate Communications at Verenium Corp.
from 2010 to 2013.
Additionally, she held the position of VP-Investor Relations & Corporate Communications at Vigil Neuroscience, Inc.

Former positions of Sarah Carmody

Companies	Position	End
VIGIL NEUROSCIENCE, INC.	Investor Relations Contact	2023-05-31
MERSANA THERAPEUTICS	Investor Relations Contact	2021-12-31
VERENIUM CORP	Investor Relations Contact	2013-11-30
MOMENTA PHARMACEUTICALS, INC.	Investor Relations Contact	-

See the detail of Sarah Carmody's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sarah Carmody's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Momenta Pharmaceuticals, Inc. Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases	Health Technology
Mersana Therapeutics, Inc. Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications	Health Technology
Verenium Corp. Verenium Corp. BiotechnologyHealth Technology Produces cellulosic ethanol derived from multiple biomass feedstocks	Health Technology
Vigil Neuroscience, Inc. Vigil Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics for neurodegenerative diseases	Health Technology

See company connections

Stock Market
Insiders
Sarah Carmody